Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

First generation inhibitors of the adenovirus proteinase.

McGrath WJ, Graziano V, Zabrocka K, Mangel WF.

FEBS Lett. 2013 Aug 2;587(15):2332-9. doi: 10.1016/j.febslet.2013.05.033. Epub 2013 May 24.

2.

Temporal and spatial control of the adenovirus proteinase by both a peptide and the viral DNA.

Mangel WF, Toledo DL, Ding J, Sweet RM, McGrath WJ.

Trends Biochem Sci. 1997 Oct;22(10):393-8. Review.

PMID:
9357315
3.

Specific interactions of the adenovirus proteinase with the viral DNA, an 11-amino-acid viral peptide, and the cellular protein actin.

Mangel WF, Baniecki ML, McGrath WJ.

Cell Mol Life Sci. 2003 Nov;60(11):2347-55. Review.

PMID:
14625681
4.

Adenain, the adenovirus endoprotease (a review).

Weber JM.

Acta Microbiol Immunol Hung. 2003;50(1):95-101. Review.

PMID:
12793204
5.

Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.

Lai L, Han X, Chen H, Wei P, Huang C, Liu S, Fan K, Zhou L, Liu Z, Pei J, Liu Y.

Curr Pharm Des. 2006;12(35):4555-64. Review.

PMID:
17168761
6.

Macrocyclic inhibitors of HCV NS3 protease.

Venkatraman S, Njoroge FG.

Expert Opin Ther Pat. 2009 Sep;19(9):1277-303. doi: 10.1517/13543770903044994. Review.

PMID:
19563268
7.

Hepatitis C virus resistance to protease inhibitors.

Halfon P, Locarnini S.

J Hepatol. 2011 Jul;55(1):192-206. doi: 10.1016/j.jhep.2011.01.011. Epub 2011 Feb 1. Review.

9.

Sometimes intermediates. Do the job!

Hilgenfeld R, Pumpor K.

Chem Biol. 2006 Mar;13(3):235-6. Review.

Supplemental Content

Support Center